N

Nektar Therapeutics
D

NKTR

37.440
USD
2.27
(6.45%)
مغلق
حجم التداول
0
الربح لكل سهم
-10
العائد الربحي
-
P/E
-4
حجم السوق
759,351,517
أصول ذات صلة المقالات

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.